23.11.2021 • NewsVersalis

Tatneft Licenses Rubber Technology from Versalis

Russian oil and rubber company Tatneft has signed a license and engineering contract with Italy’s Versalis for two new rubber plants in Togliatti. The value of the contract was not disclosed.

Under the agreement, Tatneft will build plants producing 70,000 t/y nitrile butadiene rubber (NBR) and 30,000 t/y carboxylate styrene butadiene rubber latexes (XSBR) using Versalis technology. Tatneft did not reveal when the plants would go into operation.

NBR rubbers have high resistance to aliphatic hydrocarbons, gasoline and lubricants, as well as good flexibility at low temperatures, making them suitable for use in various industrial fields. XSBR latexes are used in the production of adhesives, paper and cardboard coverings and mat bases, among other products.

Tatneft said the project is the next step in its plans for a petrochemical cluster at the site. The group bought the Togliatti rubber assets from Sibur in November 2019, saying at the time that it intended to develop them further in line with its gas and petrochemical strategy.

Sibur made the divestment as it wanted to “concentrate efforts on establishing and developing global-scale production of basic polymers, high-potential medium-tonnage products and premium special chemicals.”

Author: Elaine Burridge, Freelance Journalist

Russia’sTatneft has signed a license and engineering contract with Italy’s...
Russia’sTatneft has signed a license and engineering contract with Italy’s Versalis for two rubber projects in Togliatti. Tatneft will build plants producing 70,000 t/y nitrile butadiene rubber (NBR) and 30,000 t/y carboxylate styrene butadiene rubber latexes (XSBR). (c) eni

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.